Assertio Holdings, Inc. (ASRT)
23.48
+0.02
(+0.09%)
USD |
NASDAQ |
Jun 10, 16:00
23.47
-0.01
(-0.04%)
Pre-Market: 09:09
Assertio Holdings Gross Profit Margin (Quarterly) : 13.91% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 13.91% |
| December 31, 2025 | 32.76% |
| September 30, 2025 | 61.01% |
| June 30, 2025 | 31.75% |
| March 31, 2025 | 35.61% |
| December 31, 2024 | 43.07% |
| September 30, 2024 | 51.17% |
| June 30, 2024 | 49.88% |
| March 31, 2024 | 47.89% |
| December 31, 2023 | 55.65% |
| September 30, 2023 | 51.60% |
| June 30, 2023 | 73.03% |
| March 31, 2023 | 72.33% |
| December 31, 2022 | 71.83% |
| September 30, 2022 | 64.99% |
| June 30, 2022 | 64.43% |
| March 31, 2022 | 65.25% |
| December 31, 2021 | 63.78% |
| September 30, 2021 | 59.86% |
| June 30, 2021 | 56.10% |
| March 31, 2021 | 60.83% |
| December 31, 2020 | 55.86% |
| September 30, 2020 | 65.14% |
| June 30, 2020 | 51.05% |
| March 31, 2020 | 56.05% |
| Date | Value |
|---|---|
| December 31, 2019 | 52.71% |
| September 30, 2019 | 49.79% |
| June 30, 2019 | 51.81% |
| March 31, 2019 | 51.63% |
| December 31, 2018 | 38.62% |
| September 30, 2018 | 63.33% |
| June 30, 2018 | 55.44% |
| March 31, 2018 | 70.80% |
| December 31, 2017 | 54.19% |
| September 30, 2017 | 54.80% |
| June 30, 2017 | 54.75% |
| March 31, 2017 | 51.90% |
| December 31, 2016 | 60.95% |
| September 30, 2016 | 57.22% |
| June 30, 2016 | 58.86% |
| March 31, 2016 | 54.58% |
| December 31, 2015 | 56.76% |
| September 30, 2015 | 54.29% |
| June 30, 2015 | 47.52% |
| March 31, 2015 | 82.45% |
| December 31, 2014 | 97.03% |
| September 30, 2014 | 88.22% |
| June 30, 2014 | 89.34% |
| March 31, 2014 | 91.85% |
| December 31, 2013 | 91.05% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 98.25% |
| Merck & Co., Inc. | 71.98% |
| Theravance Biopharma, Inc. | 91.88% |
| Journey Medical Corp. | 53.99% |
| Tvardi Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.40% |
| Return on Assets | -13.14% |
| Return on Invested Capital | -25.70% |
| Profit Margin (Quarterly) | -189.8% |
| Operating Margin (Quarterly) | -185.9% |
| Return on Net Operating Assets | -19.58% |